Skip to content

Using of the absorbable scaffold containing slow releasing lidocaine in surgery area.

Evaluation of anti-pain effect of the absorbable scaffold containing slow releasing lidocaine in alveolar socket of surgical extracted impacted third molars

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
IRCT
Registry ID
IRCT201705063018N3
Enrollment
72
Registered
2017-11-08
Start date
2014-12-31
Completion date
Unknown
Last updated
2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Impacted teeth. An impacted tooth is a tooth that has failed to erupt because of obstruction by another tooth.

Interventions

Intervention 1: In the 24 patients of the intervention group, will used absorbable scaffold of lidocaine in the surgery area. Intervention 2: 24 other patients of the placebo group will be usining emp
Treatment - Surgery
Placebo
Treatment - Drugs
In the 24 patients of the intervention group, will used absorbable scaffold of lidocaine in the surgery area.
24 other patients of the placebo group will be usining empty scaffolds without lidocaine.
In 24 of the control group, post-operative routine analgesic treatments (staggel 500 mg and 400 mg jelly) are used and no other therapeutic intervention will be taken.

Sponsors

Research Vice-chancellor Tabriz Univercity of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 50 Years

Inclusion criteria

Inclusion criteria: Inclusion criteria: third molars teeth surgery in patients with bone impaction. Exclusion criteria: for patients with sinoatrial bluck heart disease and those who have adams stokes syndrom and wolff parkinson white syndrom; those taking the following drugs: quinidine, disopiramid, procainamide Amiodarone hydrochloride and are treated with caution in these patients: elderly patients; porphyrya; hepatic failure; bradycardia.

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

MeasureTime frame
Determination and comparison of pain levels in the control and placebo groups of slow-releasing lidocain as scaffolds in the surgical area of the impacted wisdom teeth. Timepoint: Immediately after surgical intervention. Method of measurement: visual analog scale way.

Secondary

MeasureTime frame
Determination and comparison of the onset time of pain in the control and placebo groups of the slow-releasing lidocaine as a scaffold in the surgical area of the impacted wisdom teeth. Timepoint: Immediately after surgical intervention. Method of measurement: In the checklist, the time of the onset of pain and the duration of the pain are asked verbally from the patient and within a few hours the patient's response will be recorded.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactNadiyeh Abdolahyazar

Tabriz University of Medical Sciences

n.abdolahyazar@yahoo.com+98 44 4422 7533

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026